Skip to main content
Clinical Trials/NCT01891786
NCT01891786
Completed
Not Applicable

A Randomised Control Trial (RCT) to Investigate the Effectiveness of a Selfmanagement Intervention and Personalised Genetic Risk Information to Reduce Risk of Coronary Heart Disease in Patients With Type 2 Diabetes.

City, University of London10 sites in 1 country211 target enrollmentJuly 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Heart Disease
Sponsor
City, University of London
Enrollment
211
Locations
10
Primary Endpoint
Coronary heart disease 10 year risk
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The primary objective of the CORDIA study is to use an effective evidence-based self-management intervention (SMI) for type 2 diabetes, with and without a novel test to give a personalised genetic and lifestyle risk of coronary heart disease, to examine their capacity to reduce the risk of coronary heart disease (CHD) and improve diabetes management in primary care patients with type 2 diabetes. The effect of these interventions on clinical, behavioural and psychological outcomes will be investigated.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stanton Newman

Professor

City, University of London

Eligibility Criteria

Inclusion Criteria

  • Males and females aged 25-70 years diagnosed with type 2 diabetes
  • White, Afro-Caribbean or Asian-Indian ethnicity
  • Most previous or baseline HbA1c ≥6.5% or 48 mmol/mol
  • Fluency in written and spoken English

Exclusion Criteria

  • Diagnosis of ischemic heart disease, stroke, Transient Ischaemic Attack (TIA) or peripheral vascular disease
  • Serious or enduring mental health problems that would prevent the patient from completing the study
  • Currently receiving treatment for a life-threatening condition (e.g., cancer) or in the terminal stages of a condition
  • Adults who cannot consent for themselves

Outcomes

Primary Outcomes

Coronary heart disease 10 year risk

Time Frame: 12 months

Coronary heart disease 10 year risk as assessed using the United Kingdon Prospective Diabetes Study (UKPDS) Risk Calculator

Secondary Outcomes

  • Psycho-social impact of the intervention(12 months)
  • Health behaviour impact of the intervention(12 months)
  • Impact of receiving genetic results(6 months)

Study Sites (10)

Loading locations...

Similar Trials